SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that the financial advisors of Emerald Legacy Advisors have joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. The team reported serving approximately $140 million in advisory, brokerage and retirement plan assets.* They join LPL from Wells Fargo Advisors Financial Network. Based in Kansas City, Mo., Emerald Legacy Advisors is built on decades of experience and intergenerational ties within the financial services industry. Managing partners Jim McMurtry, CFP® and Allie Konieczka — daughter of McMurtry’s retired longtime business partner, Colleen Konieczka — lead the firm alongside McMurtry’s daughter, Michelle Reek, carrying the practice’s esteemed legacy forward. The firm officially rebranded to Emerald Legacy Advisors...

FORT LAUDERDALE, Fla., April 07, 2026 (GLOBE NEWSWIRE) — EdgeMode, Inc. (OTC: EDGM), a global energy and AI data center infrastructure company, today announced the signing of a Memorandum of Understanding with a leading solid oxide fuel cell provider to support the deployment of scalable, on-site energy solutions across its growing AI data center portfolio. The agreement represents a significant milestone for EdgeMode, providing a scalable pathway to deliver power at speed and at scale, one of the most critical constraints currently facing AI infrastructure development globally. Under the MoU, EdgeMode and the technology provider will collaborate on deploying solid oxide fuel cell microgrid solutions to power EdgeMode’s AI data center developments, initially targeting deployments across its Spanish pipeline, with the framework designed...

ISELIN, N.J., April 07, 2026 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it submitted a formal dispute resolution request (FDRR) to the U.S. Food and Drug Administration (FDA) as a follow-up to its recent Type A meeting regarding the December 30, 2025 Complete Response Letter (CRL) for the Biologics License Application (BLA) for ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the treatment of neovascular age-related macular degeneration. The FDA has accepted the FDRR and has granted a meeting with the deciding official to be conducted in April 2026. Subsequent to receiving the CRL in December 2025, Outlook Therapeutics has engaged with the FDA on multiple occasions, including...

Five abstracts accepted including Late-breaking Science oral and poster presentations of Phase 3 X-TOLE2 study results for azetukalner in focal onset seizures Poster presentations also include long-term efficacy and safety data from X-TOLE open-label extension study of azetukalner, as well as real-world data regarding the burden of titration and need for no-titration options in epilepsyVANCOUVER, British Columbia and BOSTON, MA, April 07, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced multiple presentations at the upcoming American Academy of Neurology (AAN) Annual Meeting, taking place April 18-22, 2026 in Chicago, Illinois....

CLEVELAND, April 07, 2026 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Keith A. Goldan as a new independent member to its Board of Directors, effective as of April 1, 2026. Mr. Goldan will also serve as Chairman of Abeona’s Audit Committee. Mr. Goldan brings more than two decades of financial leadership experience across publicly traded commercial-stage biotechnology and specialty pharmaceutical companies. His appointment to the Board of Directors reflects Abeona’s continued focus on strengthening its leadership team to advance both strategic and financial objectives. “On behalf of the Board, we are delighted to welcome Keith to Abeona,” said Michael Amoroso, Chairman of Abeona’s Board of Directors. “Keith’s deep experience in capital markets, corporate development, and operational...

                                                                             Clermont-Ferrand, April 7, 2026 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN 2025 Universal Registration Document Michelin filed its 2025 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 3, 2026. It is available to the public under the conditions set out in the applicable regulations and can be consulted/downloaded at the Company’s website, www.michelin.com and on the AMF’s website (www.amf-france.org). The Universal Registration Document contains:The 2025 Annual Financial Report; The Report of the Supervisory Board on Corporate Governance, covering the components of corporate officer compensation submitted to shareholders at the Annual Meeting to be held on May 22, 2026; The Sustainability Statement; The Duty of Care...

Former Advisor to Certain Big Four Firms as Well as World Renowned Financial Services Firms Including Renaissance Technologies, Greenlight Capital, and Lord Abbett Brings 40+ Years of Audit and Financial Services Leadership ROSEVILLE, MN, April 07, 2026 (GLOBE NEWSWIRE) — SecureTech Innovations, Inc. (OTCQB: SCTH), a diversified technology holding company advancing artificial intelligence initiatives, industrial 3D printing and manufacturing technologies, and blockchain-based digital infrastructure and assets, today announced the nomination of Robert V. Castro, CPA, CGMA, to serve as an Independent Director and member of the Company’s Audit, Compensation, and Nomination Committees. Mr. Castro brings more than forty years of audit, tax, and business advisory experience, the majority of which was spent at BDO Seidman, LLP (now BDO...